Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Teva Pharmaceutical Industries ADR (TEVA)

Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,251,620
  • Shares Outstanding, K 1,132,641
  • Annual Sales, $ 15,846 M
  • Annual Income, $ -559,000 K
  • 60-Month Beta 0.88
  • Price/Sales 1.28
  • Price/Cash Flow 5.14
  • Price/Book 3.12
Trade TEVA with:

Options Overview Details

View History
  • Implied Volatility 34.47% ( -1.51%)
  • Historical Volatility 27.03%
  • IV Percentile 32%
  • IV Rank 15.47%
  • IV High 75.10% on 10/05/23
  • IV Low 27.03% on 06/11/24
  • Put/Call Vol Ratio 0.54
  • Today's Volume 7,087
  • Volume Avg (30-Day) 18,695
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 684,932
  • Open Int (30-Day) 663,162

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.62
  • Number of Estimates 5
  • High Estimate 0.65
  • Low Estimate 0.58
  • Prior Year 0.58
  • Growth Rate Est. (year over year) +6.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.01 +4.97%
on 09/10/24
19.08 -6.42%
on 09/04/24
-0.44 (-2.38%)
since 08/19/24
3-Month
15.62 +14.31%
on 07/01/24
19.08 -6.42%
on 09/04/24
+0.84 (+4.97%)
since 06/18/24
52-Week
8.06 +121.66%
on 10/23/23
19.08 -6.42%
on 09/04/24
+7.56 (+73.52%)
since 09/19/23

Most Recent Stories

More News
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?

Teva Pharmaceutical Industries Limited’s TEVA stock has risen 72.5% so far this year compared with an increase of 17.9% for the industry. The stock has also outperformed the sector and the S&P 500, as...

SNY : 58.17 (+1.22%)
JNJ : 164.86 (-0.78%)
TEVA : 17.83 (-0.28%)
ABBV : 193.20 (+0.13%)
Ozempic Medicare Negotiations Target Big Pharma in 2027

The anticipated 2027 Medicare drug negotiations are expected to impact several blockbuster drugs, with Novo Nordisk’s (NOVO) Ozempic, Pfizer’s (PFE) Ibrance and Xtandi, and GSK’s (GSK) Trelegy Ellipta...

PFE : 29.58 (-0.57%)
GSK : 41.72 (-1.67%)
TEVA : 17.83 (-0.28%)
ABBV : 193.20 (+0.13%)
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves targeted...

ALZN : 1.7400 (+0.58%)
VNDA : 4.62 (-6.67%)
ITCI : 75.91 (+1.62%)
TEVA : 17.83 (-0.28%)
ABBV : 193.20 (+0.13%)
Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript

TEVA earnings call for the period ending June 30, 2024.

TEVA : 17.83 (-0.28%)
Option Volatility And Earnings Report For July 29 – August 2

This week we have Apple, Advanced Micro Devices, Amazon, Pfizer, Coinbase, Meta Platforms, Intel, Exxon Mobil, Boeing, PayPal, Starbucks, McDonald’s and Chevron all set to report.

AAPL : 229.22 (+3.87%)
AMD : 156.88 (+5.79%)
AMZN : 189.48 (+1.64%)
PFE : 29.58 (-0.57%)
COIN : 167.41 (+2.93%)
META : 560.87 (+4.26%)
INTC : 21.21 (+2.12%)
XOM : 116.75 (+1.89%)
BA : 154.60 (-0.33%)
PYPL : 77.68 (+6.24%)
SBUX : 96.49 (+0.38%)
MCD : 293.41 (+0.47%)
3 No-Brainer Stocks to Buy With $200 Right Now

A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.

COMP : 6.33 (-0.94%)
ABNB : 129.09 (+5.45%)
TEVA : 17.83 (-0.28%)
PINS : 30.76 (+2.91%)
Purdue Pharma's Settlement Blocked; Opioid Crisis Accountability in Focus

The U.S. Supreme Court on Thursday blocked Purdue Pharma's bankruptcy settlement, which would have shielded the Sackler family from lawsuits related to their role in the opioid crisis. The decision reversed...

JNJ : 164.86 (-0.78%)
ENDP : 0.2926 (-5.00%)
TEVA : 17.83 (-0.28%)
MNK : 0.3402 (-14.97%)
ABC : 179.98 (-0.23%)
CAH : 110.95 (-0.41%)
MCK : 509.53 (-0.41%)
Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript

TEVA earnings call for the period ending March 31, 2024.

TEVA : 17.83 (-0.28%)
Teva Pharmaceuticals Stock Has Unusual Call Options Activity After Its Q1 Results

Teva Pharmaceuticals, the generic drug maker, posted good Q1 results today, reaffirming its forecast for significant free cash flow in 2024. That led to unusual call options activity based on a Barchart...

TEVA : 17.83 (-0.28%)
Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead

Three highly successful billionaire money managers are paring down their respective stakes in artificial intelligence (AI) titan Nvidia and purchasing shares of six beaten-down value stocks.

NVDA : 118.15 (+4.22%)
T : 21.33 (-1.84%)
TEVA : 17.83 (-0.28%)
PFE : 29.58 (-0.57%)
BABA : 88.38 (+4.69%)
GM : 48.43 (-0.47%)
NEE : 82.35 (-2.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets,...

See More

Key Turning Points

3rd Resistance Point 18.47
2nd Resistance Point 18.23
1st Resistance Point 18.06
Last Price 17.83
1st Support Level 17.64
2nd Support Level 17.41
3rd Support Level 17.23

See More

52-Week High 19.08
Last Price 17.83
Fibonacci 61.8% 14.87
Fibonacci 50% 13.57
Fibonacci 38.2% 12.27
52-Week Low 8.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar